Hangdi Xu

3.6k total citations · 1 hit paper
20 papers, 2.9k citations indexed

About

Hangdi Xu is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Hangdi Xu has authored 20 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Epidemiology and 4 papers in Cancer Research. Recurrent topics in Hangdi Xu's work include Hepatitis B Virus Studies (4 papers), Liver Disease Diagnosis and Treatment (3 papers) and Cancer-related molecular mechanisms research (3 papers). Hangdi Xu is often cited by papers focused on Hepatitis B Virus Studies (4 papers), Liver Disease Diagnosis and Treatment (3 papers) and Cancer-related molecular mechanisms research (3 papers). Hangdi Xu collaborates with scholars based in China and United States. Hangdi Xu's co-authors include Jiliang He, Zhi Chen, Guangzhong Song, Qiao Yang, Min Zheng, Yanning Liu, Shuping Li, Yu Shi, Feng Chen and Ying Yang and has published in prestigious journals such as PLoS ONE, Analytical Biochemistry and Medicine.

In The Last Decade

Hangdi Xu

19 papers receiving 2.9k citations

Hit Papers

Resveratrol Reduces the Proinflammatory Effects and Lipop... 2014 2026 2018 2022 2014 500 1000 1.5k 2.0k 2.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hangdi Xu China 11 1.1k 877 574 478 310 20 2.9k
Guangzhong Song China 7 1.1k 0.9× 864 1.0× 576 1.0× 448 0.9× 310 1.0× 9 2.8k
Shuping Li China 12 1.1k 1.0× 1.1k 1.3× 606 1.1× 760 1.6× 309 1.0× 21 3.3k
Wenbo Zhang United States 29 1.4k 1.3× 442 0.5× 173 0.3× 332 0.7× 256 0.8× 98 3.4k
Yanning Liu China 27 3.3k 3.0× 1.3k 1.5× 586 1.0× 992 2.1× 344 1.1× 73 6.2k
Mohamed El Gazzar United States 35 1.4k 1.3× 1.8k 2.0× 147 0.3× 620 1.3× 169 0.5× 82 3.8k
Barbara K. Yoza United States 36 1.6k 1.4× 1.4k 1.6× 150 0.3× 712 1.5× 574 1.9× 65 3.7k
Noriyuki Sonoda Japan 32 1.9k 1.7× 346 0.4× 324 0.6× 534 1.1× 405 1.3× 58 4.5k
Yuehua Li China 42 2.8k 2.5× 1.3k 1.5× 275 0.5× 868 1.8× 90 0.3× 157 5.5k

Countries citing papers authored by Hangdi Xu

Since Specialization
Citations

This map shows the geographic impact of Hangdi Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hangdi Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hangdi Xu more than expected).

Fields of papers citing papers by Hangdi Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hangdi Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hangdi Xu. The network helps show where Hangdi Xu may publish in the future.

Co-authorship network of co-authors of Hangdi Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Hangdi Xu. A scholar is included among the top collaborators of Hangdi Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hangdi Xu. Hangdi Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Su, Hua, et al.. (2024). Noncoding RNAs in chronic obstructive pulmonary disease: From pathogenesis to therapeutic targets. Non-coding RNA Research. 9(4). 1111–1119.
2.
Xu, Hangdi, Yanjie Hu, Xiuming Peng, & Enguo Chen. (2023). Prediction of prognostic and immune therapy response in lung adenocarcinoma based on MHC-I-related genes. Immunopharmacology and Immunotoxicology. 46(1). 93–106. 1 indexed citations
3.
Xu, Hangdi, Jisong Zhang, Shan Xu, et al.. (2021). Exploring the Effect of Differentially Expressed Long Non-coding RNAs Driven by Copy Number Variation on Competing Endogenous RNA Network by Mining Lung Adenocarcinoma Data. Frontiers in Cell and Developmental Biology. 8. 627436–627436. 7 indexed citations
4.
Qian, Jing, Hangdi Xu, Dongqing Lv, et al.. (2021). Babaodan controls excessive immune responses and may represent a cytokine-targeted agent suitable for COVID-19 treatment. Biomedicine & Pharmacotherapy. 139. 111586–111586. 10 indexed citations
5.
Zhou, Yong, Hangdi Xu, Pan Zhou, et al.. (2020). Validation of novel automatic ultra-wideband radar for sleep apnea detection. Journal of Thoracic Disease. 12(4). 1286–1295. 30 indexed citations
6.
Xu, Hangdi, Wei Lou, & Fangfang Fu. (2019). Association between osteopontin expression and asthma: a meta-analysis. Journal of International Medical Research. 47(8). 3513–3521. 11 indexed citations
7.
Wang, Fang, et al.. (2019). Pituitrin use is associated with an increased risk of inguinal hematomas and pseudoaneurysms in patients undergoing femoral artery puncture. Journal of International Medical Research. 47(7). 2976–2986. 3 indexed citations
8.
Chen, Enguo, Zhang Bao, Yu Chen, et al.. (2019). Template-ready PCR method for detection of human telomerase reverse transcriptase mRNA in sputum. Analytical Biochemistry. 577. 34–41. 2 indexed citations
9.
Yang, Fan, et al.. (2019). Brain metastasis from early stage endometrial carcinoma 13 years after primary treatment: a case report and review of the literature.. PubMed. 12(5). 1806–1810. 3 indexed citations
10.
Zhou, Yong, Wenjing Ruan, Joy Q. Jin, et al.. (2019). Pulmonary vascular involvement of IgG4-related disease. Medicine. 98(6). e14437–e14437. 10 indexed citations
11.
Xu, Hangdi, et al.. (2019). Association between obstructive sleep apnea and lipid metabolism during REM and NREM sleep. Sleep Medicine. 64. S425–S425. 1 indexed citations
13.
Zhao, Mingfei, Hangdi Xu, Buyi Zhang, et al.. (2015). Impact of nuclear factor erythroid-derived 2–like 2 and p62/sequestosome expression on prognosis of patients with gliomas. Human Pathology. 46(6). 843–849. 31 indexed citations
14.
Zhao, Mingfei, Feng Liang, Hangdi Xu, Wei Yan, & Jianmin Zhang. (2015). Methylene blue exerts a neuroprotective effect against traumatic brain injury by promoting autophagy and inhibiting microglial activation. Molecular Medicine Reports. 13(1). 13–20. 47 indexed citations
15.
Zhao, Mingfei, Hangdi Xu, Feng Liang, Jiliang He, & Jianmin Zhang. (2014). Association of osteopontin expression with the prognosis of glioma patient: a meta-analysis. Tumor Biology. 36(1). 429–436. 12 indexed citations
16.
Yang, Ying, Shuping Li, Qiao Yang, et al.. (2014). Resveratrol Reduces the Proinflammatory Effects and Lipopolysaccharide- Induced Expression of HMGB1 and TLR4 in RAW264.7 Cells. Cellular Physiology and Biochemistry. 33(5). 1283–1292. 2700 indexed citations breakdown →
17.
Xu, Hangdi, et al.. (2013). Association between Mannose-Binding Lectin Gene Polymorphisms and Hepatitis B Virus Infection: A Meta-Analysis. PLoS ONE. 8(10). e75371–e75371. 21 indexed citations
18.
Li, Sujuan, Qiao Yang, Hangdi Xu, et al.. (2013). The effects of hepatitis C virus core protein on the expression of miR-122 in vitro. Virology Journal. 10(1). 98–98. 12 indexed citations
19.
Xu, Hangdi, Mingfei Zhao, Jiliang He, & Zhi Chen. (2013). Association between cytotoxic T-lymphocyte associated protein 4 gene +49 A/G polymorphism and chronic infection with hepatitis B virus: A meta-analysis. Journal of International Medical Research. 41(3). 559–567. 14 indexed citations
20.
Xiao, Yao, et al.. (1995). [Hemodynamic changes in portal system after transjugular intrahepatic portosystemic shunts (TIPS)].. PubMed. 33(8). 476–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026